We are developing PointCheck™, the first device for non-invasive white cell monitoring. PointCheck™ is fast, portable and simple to use. By removing the need for a blood draw, millions of immunosuppressed patients can now be tested more frequently, moving towards improved quality of life and improved clinical outcomes.
This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.
A Simple At-Home Blood Test
Portable and designed for use in the home, the finger-based test takes a minute to noninvasively capture enough information to evaluate white cell levels.
No Need for a Blood Sample
By shining light into the skin surrounding the fingernail, PointCheck™ is able to image the blood cells flowing through superficial capillaries. Our A.I. algorithms then determine whether white blood cell levels are dangerously low.
Identifying Elevated Risk of Infection
Risk of infection is a huge worry for chemotherapy patients. PointCheck™ helps show when risk of infection is elevated, to help trigger preventative treatments before infection occurs.
What People Are Saying About Us
“This is a simple, yet highly effective technological solution to a common problem in cancer care that will improve cancer treatment at local clinics and at home”
Tiffani Bailey Lash, Ph.D., director of the NIBIB program for Point of Care Technologies.
“Leuko puede mejorar la calidad de vida de muchos pacientes a la vez que suponer un ahorro importante de los costes sanitarios”
Regina Revilla, president of ASEBIO the Spanish Bioindustry Association.
